Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-09-27 Sale |
2021-09-27 7:21 pm |
ACCELERON PHARMA INC | XLRN | KANGO SUJAY EVP, Chief Commercial Officer |
5,000 | $175 | $875,000 | 43,509 (Direct) |
View |
| 2021-09-23 Sale |
2021-09-24 7:36 pm |
ACCELERON PHARMA INC | XLRN | MCLAUGHLIN KEVIN F SVP, CFO and Treasurer |
25,000 | $160.33 | $4,008,127 | 82,238 (Direct) |
View |
| 2021-09-21 Sale |
2021-09-22 6:08 pm |
ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. |
6,650 | $150.05 | $997,833 | 18,923 (Direct) |
View |
| 2021-09-21 Sale |
2021-09-22 5:56 pm |
ACCELERON PHARMA INC | XLRN | KANGO SUJAY EVP, Chief Commercial Officer |
5,000 | $150.03 | $750,150 | 48,509 (Direct) |
View |
| 2021-09-08 Sale |
2021-09-09 5:07 pm |
ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. |
1,413 | $130 | $183,690 | 18,923 (Direct) |
View |
| 2021-07-01 Sale |
2021-07-02 9:15 pm |
ACCELERON PHARMA INC | XLRN | Dable Habib J CEO and President |
100,000 | $126.83 | $12,682,942 | 640,636 (Direct) |
View |
| 2021-04-19 Sale |
2021-04-21 4:46 pm |
ACCELERON PHARMA INC | XLRN | MCCOURT Thomas A Director |
7,500 | $119.26 | $894,425 | 6,044 (Direct) |
View |
| 2021-04-05 Sale |
2021-04-05 8:27 pm |
ACCELERON PHARMA INC | XLRN | Zakrzewski Joseph S Director |
10,000 | $140.73 | $1,407,343 | 34,499 (Direct) |
View |
| 2021-04-05 Sale |
2021-04-05 8:17 pm |
ACCELERON PHARMA INC | XLRN | Smith Karen L. Director |
11,864 | $140.19 | $1,663,156 | 19,457 (Direct) |
View |
| 2021-04-01 Sale |
2021-04-02 6:08 pm |
ACCELERON PHARMA INC | XLRN | Zakrzewski Joseph S Director |
10,000 | $134.64 | $1,346,382 | 44,499 (Direct) |
View |
| 2021-04-01 Sale |
2021-04-02 6:00 pm |
ACCELERON PHARMA INC | XLRN | Smith Karen L. Director |
8,925 | $136.47 | $1,218,003 | 31,321 (Direct) |
View |
| 2021-03-02 Sale |
2021-03-04 5:17 pm |
ACCELERON PHARMA INC | XLRN | KANGO SUJAY EVP, Chief Commercial Officer |
5,000 | $136.01 | $680,059 | 54,396 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-11-19 Equity Swap |
2021-11-22 09:12 am |
N/A N/A |
ACCELERON PHARMA INC | XLRN | Zakrzewski Joseph S Director |
34,499 | $0 | 0 (Direct) |
View |
| 2021-11-19 Equity Swap |
2021-11-22 09:11 am |
N/A N/A |
ACCELERON PHARMA INC | XLRN | Malik Kemal Director |
1,622 | $0 | 0 (Direct) |
View |
| 2021-11-19 Equity Swap |
2021-11-22 09:10 am |
N/A N/A |
ACCELERON PHARMA INC | XLRN | Hite Christopher Director |
930 | $0 | 0 (Direct) |
View |
| 2021-11-19 Equity Swap |
2021-11-22 09:09 am |
N/A N/A |
ACCELERON PHARMA INC | XLRN | Smith Karen L. Director |
1,622 | $0 | 0 (Direct) |
View |
| 2021-11-19 Equity Swap |
2021-11-22 09:08 am |
N/A N/A |
ACCELERON PHARMA INC | XLRN | MCCOURT Thomas A Director |
6,044 | $0 | 0 (Direct) |
View |
| 2021-11-19 Equity Swap |
2021-11-22 09:08 am |
N/A N/A |
ACCELERON PHARMA INC | XLRN | Kearney Terrence C Director |
6,749 | $0 | 0 (Direct) |
View |
| 2021-11-19 Equity Swap |
2021-11-22 09:07 am |
N/A N/A |
ACCELERON PHARMA INC | XLRN | Hamill Laura Director |
474 | $0 | 0 (Direct) |
View |
| 2021-11-19 Equity Swap |
2021-11-22 09:06 am |
N/A N/A |
ACCELERON PHARMA INC | XLRN | Nader Francois Director |
6,749 | $0 | 0 (Direct) |
View |
| 2021-11-19 Equity Swap |
2021-11-22 09:05 am |
N/A N/A |
ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. |
23,423 | $0 | 0 (Direct) |
View |
| 2021-11-19 Equity Swap |
2021-11-22 09:04 am |
N/A N/A |
ACCELERON PHARMA INC | XLRN | KANGO SUJAY EVP, Chief Commercial Officer |
18,509 | $0 | 0 (Direct) |
View |
| 2021-11-19 Equity Swap |
2021-11-22 09:04 am |
N/A N/A |
ACCELERON PHARMA INC | XLRN | Backstrom Jay T. EVP, Research and Development |
21,233 | $0 | 0 (Direct) |
View |
| 2021-11-19 Equity Swap |
2021-11-22 09:03 am |
N/A N/A |
ACCELERON PHARMA INC | XLRN | MCLAUGHLIN KEVIN F SVP, CFO and Treasurer |
10,681 | $0 | 0 (Direct) |
View |
| 2021-11-19 Equity Swap |
2021-11-22 09:02 am |
N/A N/A |
ACCELERON PHARMA INC | XLRN | Dable Habib J CEO and President |
98,450 | $0 | 0 (Direct) |
View |
| 2021-11-09 Exercise |
2021-11-12 4:15 pm |
N/A 2024-08-01 |
ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. |
4,500 | $0 | 23,423 (Direct) |
View |
| 2021-11-09 Exercise |
2021-11-12 4:15 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. |
4,500 | $29.37 | 23,423 (Direct) |
View |
| 2021-09-27 Exercise |
2021-09-27 7:21 pm |
N/A 2028-03-01 |
ACCELERON PHARMA INC | XLRN | KANGO SUJAY EVP, Chief Commercial Officer |
5,000 | $0 | 43,509 (Direct) |
View |
| 2021-09-27 Exercise |
2021-09-27 7:21 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | KANGO SUJAY EVP, Chief Commercial Officer |
5,000 | $40.61 | 43,509 (Direct) |
View |
| 2021-09-23 Exercise |
2021-09-24 7:36 pm |
N/A 2027-03-02 |
ACCELERON PHARMA INC | XLRN | MCLAUGHLIN KEVIN F SVP, CFO and Treasurer |
25,000 | $0 | 82,238 (Direct) |
View |
| 2021-09-23 Exercise |
2021-09-24 7:36 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | MCLAUGHLIN KEVIN F SVP, CFO and Treasurer |
2,500 | $30.17 | 82,238 (Direct) |
View |
| 2021-09-23 Exercise |
2021-09-24 7:36 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | MCLAUGHLIN KEVIN F SVP, CFO and Treasurer |
15,000 | $40.61 | 82,238 (Direct) |
View |
| 2021-09-23 Exercise |
2021-09-24 7:36 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | MCLAUGHLIN KEVIN F SVP, CFO and Treasurer |
7,500 | $41.64 | 82,238 (Direct) |
View |
| 2021-09-21 Exercise |
2021-09-22 6:08 pm |
N/A 2027-03-02 |
ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. |
6,650 | $0 | 18,923 (Direct) |
View |
| 2021-09-21 Exercise |
2021-09-22 6:08 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. |
5,200 | $30.17 | 18,923 (Direct) |
View |
| 2021-09-21 Exercise |
2021-09-22 6:08 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. |
1,450 | $41.2 | 18,923 (Direct) |
View |
| 2021-09-21 Exercise |
2021-09-22 5:56 pm |
N/A 2028-03-01 |
ACCELERON PHARMA INC | XLRN | KANGO SUJAY EVP, Chief Commercial Officer |
5,000 | $0 | 48,509 (Direct) |
View |
| 2021-09-21 Exercise |
2021-09-22 5:56 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | KANGO SUJAY EVP, Chief Commercial Officer |
5,000 | $40.61 | 48,509 (Direct) |
View |
| 2021-09-07 Tax Withholding |
2021-09-09 5:07 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. |
587 | $129.36 | 18,923 (Direct) |
View |
| 2021-07-01 Exercise |
2021-07-02 9:15 pm |
N/A 2026-12-01 |
ACCELERON PHARMA INC | XLRN | Dable Habib J CEO and President |
100,000 | $0 | 640,636 (Direct) |
View |
| 2021-07-01 Exercise |
2021-07-02 9:15 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | Dable Habib J CEO and President |
100,000 | $35.04 | 640,636 (Direct) |
View |
| 2021-06-07 Tax Withholding |
2021-06-08 6:53 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. |
108 | $126.69 | 20,923 (Direct) |
View |
| 2021-02-12 Tax Withholding |
2021-06-08 6:48 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | KANGO SUJAY EVP, Chief Commercial Officer |
887 | $130.87 | 18,509 (Direct) |
View |
| 2021-04-19 Exercise |
2021-04-21 4:46 pm |
N/A 2028-03-01 |
ACCELERON PHARMA INC | XLRN | MCCOURT Thomas A Director |
7,500 | $0 | 6,044 (Direct) |
View |
| 2021-04-19 Exercise |
2021-04-21 4:46 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | MCCOURT Thomas A Director |
7,500 | $40.61 | 6,044 (Direct) |
View |
| 2021-04-05 Exercise |
2021-04-05 8:27 pm |
N/A 2023-12-05 |
ACCELERON PHARMA INC | XLRN | Zakrzewski Joseph S Director |
10,000 | $0 | 34,499 (Direct) |
View |
| 2021-04-05 Exercise |
2021-04-05 8:27 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | Zakrzewski Joseph S Director |
10,000 | $24.11 | 34,499 (Direct) |
View |
| 2021-04-05 Exercise |
2021-04-05 8:17 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | Smith Karen L. Director |
2,050 | $52.99 | 19,457 (Direct) |
View |
| 2021-04-05 Exercise |
2021-04-05 8:17 pm |
N/A 2027-11-15 |
ACCELERON PHARMA INC | XLRN | Smith Karen L. Director |
8,925 | $0 | 19,457 (Direct) |
View |
| 2021-04-05 Exercise |
2021-04-05 8:17 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | Smith Karen L. Director |
5,000 | $35.34 | 19,457 (Direct) |
View |
| 2021-04-05 Exercise |
2021-04-05 8:17 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | Smith Karen L. Director |
1,875 | $41.64 | 19,457 (Direct) |
View |
| 2021-04-01 Exercise |
2021-04-02 6:08 pm |
N/A 2023-12-05 |
ACCELERON PHARMA INC | XLRN | Zakrzewski Joseph S Director |
10,000 | $0 | 44,499 (Direct) |
View |
| 2021-04-01 Exercise |
2021-04-02 6:08 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | Zakrzewski Joseph S Director |
10,000 | $24.11 | 44,499 (Direct) |
View |
| 2021-04-01 Exercise |
2021-04-02 6:00 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | Smith Karen L. Director |
2,050 | $52.99 | 31,321 (Direct) |
View |
| 2021-04-01 Exercise |
2021-04-02 6:00 pm |
N/A 2027-11-15 |
ACCELERON PHARMA INC | XLRN | Smith Karen L. Director |
8,925 | $0 | 31,321 (Direct) |
View |
| 2021-04-01 Exercise |
2021-04-02 6:00 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | Smith Karen L. Director |
5,000 | $35.34 | 31,321 (Direct) |
View |
| 2021-04-01 Exercise |
2021-04-02 6:00 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | Smith Karen L. Director |
1,875 | $41.64 | 31,321 (Direct) |
View |
| 2021-03-02 Exercise |
2021-03-04 5:17 pm |
N/A 2028-03-01 |
ACCELERON PHARMA INC | XLRN | KANGO SUJAY EVP, Chief Commercial Officer |
5,000 | $0 | 54,396 (Direct) |
View |
| 2021-03-02 Exercise |
2021-03-04 5:17 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | KANGO SUJAY EVP, Chief Commercial Officer |
5,000 | $40.61 | 54,396 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-02 7:50 pm |
N/A 2031-01-29 |
ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. |
23,674 | $0 | 39,837 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-02 7:46 pm |
N/A 2031-01-29 |
ACCELERON PHARMA INC | XLRN | MCLAUGHLIN KEVIN F SVP, CFO and Treasurer |
23,674 | $0 | 29,487 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-02 7:42 pm |
N/A 2031-01-29 |
ACCELERON PHARMA INC | XLRN | KANGO SUJAY EVP, Chief Commercial Officer |
26,305 | $0 | 40,292 (Direct) |
View |
| 2021-01-04 Exercise(A) |
2021-02-02 7:35 pm |
N/A 2028-03-01 |
ACCELERON PHARMA INC | XLRN | KANGO SUJAY EVP, Chief Commercial Officer |
10,000 | $0 | 53,987 (Direct) |
View |
| 2021-01-04 Exercise(A) |
2021-02-02 7:35 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | KANGO SUJAY EVP, Chief Commercial Officer |
10,000 | $40.61 | 53,987 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-02 7:15 pm |
N/A 2031-01-29 |
ACCELERON PHARMA INC | XLRN | Backstrom Jay T. EVP, Research and Development |
26,305 | $0 | 41,677 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-02 7:10 pm |
N/A 2031-01-29 |
ACCELERON PHARMA INC | XLRN | Dable Habib J CEO and President |
81,023 | $0 | 162,811 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-02 7:00 pm |
N/A 2031-01-29 |
ACCELERON PHARMA INC | XLRN | Zakrzewski Joseph S Director |
4,844 | $0 | 37,721 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-02 6:52 pm |
N/A 2031-01-29 |
ACCELERON PHARMA INC | XLRN | Smith Karen L. Director |
4,844 | $0 | 7,783 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-02 6:49 pm |
N/A 2031-01-29 |
ACCELERON PHARMA INC | XLRN | MCCOURT Thomas A Director |
4,844 | $0 | 9,266 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-02 6:46 pm |
N/A 2031-01-29 |
ACCELERON PHARMA INC | XLRN | Malik Kemal Director |
4,844 | $0 | 4,844 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-02 6:41 pm |
N/A 2031-01-29 |
ACCELERON PHARMA INC | XLRN | Kearney Terrence C Director |
4,844 | $0 | 9,971 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-02 6:38 pm |
N/A 2031-01-29 |
ACCELERON PHARMA INC | XLRN | Hite Christopher Director |
2,778 | $0 | 2,778 (Direct) |
View |